A window on disease pathogenesis and potential therapeutic strategies: Molecular imaging for arthritis

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Gompels, Luke L ^a   Paleolog, Ewa M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY TC 99M; CHOLINE C 11; COPPER 64; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 ANTIBODY FAB FRAGMENT IN 111; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 ANTIBODY FAB FRAGMENT TC 99M; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GALLIUM 67; GALLIUM CITRATE GA 67; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; INDIUM 111; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT I 111; METHYLCHOLINE C 11; OXIDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TECHNETIUM 99M; TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY TC 99M; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ARTHRITIS; AUTOIMMUNE DISEASE; BIOLUMINESCENCE; BLOOD VESSEL PERMEABILITY; BONE METABOLISM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLLAGEN INDUCED ARTHRITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; JOINT RADIOGRAPHY; JOINT SCINTISCANNING; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MOLECULAR INTERACTION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DIAGNOSIS; REGULATORY T LYMPHOCYTE; REPEATED DRUG DOSE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNOVIOCYTE; SYNOVITIS; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

ARTHRITIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MOLECULAR IMAGING;

EID: 79960908175     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3197     Document Type: Review

References (97)

1. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995, 22:1792-1796.
2. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998, 41:1343-1355. 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9, 9704632.
3. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
4. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997, 350:503-508. 10.1016/S0140-6736(97)07226-7, 9274595.
5. Jones G, Ding C, Scott F, Glisson M, Cicuttini F. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage 2004, 12:169-174. 10.1016/j.joca.2003.08.010, 14723876.
6. de Bois MH, Pauwels EK, Breedveld FC. New agents for scintigraphy in rheumatoid arthritis. Eur J Nucl Med 1995, 22:1339-1346. 10.1007/BF00801624, 8575488.
7. Oyen WJ, Boerman OC, van der Laken CJ, Claessens RA, van der Meer JW, Corstens FH. The uptake mechanisms of inflammation- and infection-localizing agents. Eur J Nucl Med 1996, 23:459-465. 10.1007/BF01247377, 8612669.
8. Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981, 24:1550-1560. 10.1002/art.1780241215, 7326067.
9. Dams ET, Oyen WJ, Boerman OC, Storm G, Laverman P, Kok PJ, Buijs WC, Bakker H, van der Meer JW, Corstens FH. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 2000, 41:622-630.
10. Kaya M, Tuna H, Fatih Firat M, Tuna F, Seren G, Necmi Yigitbasi O. (99m) Tc-dextran scintigraphy to detect disease activity in patients with rheumatoid arthritis. Nucl Med Commun 2004, 25:597-601. 10.1097/01.mnm.0000126632.32413.2e, 15167520.
11. Arzu Gencoglu E, Aras G, Kucuk O, Atay G, Tutak I, Ataman S, Soylu A, Ibis E. Comparison of Tc-99 m HIG and three-phase Tc-99 m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy. Clin Nucl Med 2003, 28:277-285. 10.1097/00003072-200304000-00002, 12642704.
12. Adams BK, Al Attia HM, Khadim RA, Al Haider ZY. 99Tc(m) nanocolloid scintigraphy: a reliable way to detect active joint disease in patients with peripheral joint pain. Nucl Med Commun 2001, 22:315-318. 10.1097/00006231-200103000-00008, 11314764.
13. Desaulniers M, Fuks A, Hawkins D, Lacourciere Y, Rosenthall L. Radiotechnetium polyphosphate joint imaging. J Nucl Med 1974, 15:417-423.
14. Helfgott S, Rosenthall L, Esdaile J, Tannenbaum H. Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis. J Rheumatol 1982, 9:939-941.
15. Fogelman I. Skeletal uptake of diphosphonate: a review. Eur J Nucl Med 1980, 5:473-476.
16. Jamar F, Houssiau FA, Devogelaer JP, Chapman PT, Haskard DO, Beaujean V, Beckers C, Manicourt DH, Peters AM. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology (Oxford) 2002, 41:53-61. 10.1093/rheumatology/41.1.53, 11792880.
17. Barrera P, van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van Lent PL, van de Putte LB, Corstens FH. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 2000, 39:870-874. 10.1093/rheumatology/39.8.870, 10952741.
18. Barrera P, Oyen WJ, Boerman OC, van Riel PL. Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:825-828. 10.1136/ard.62.9.825, 1754647, 12922953.
19. Lopes FP, de Azevedo MN, Marchiori E, da Fonseca LM, de Souza SA, Gutfi len B. Use of 99mTc-anti-CD3 scintigraphy in the differential diagnosis of rheumatic diseases. Rheumatology (Oxford) 2010, 49:933-939. 10.1093/rheumatology/kep471, 20129997.
20. Notley CA, McCann FE, Inglis JJ, Williams RO. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis. Arthritis Rheum 62:171-178. 10.1002/art.25058, 20039431.
21. Turk MJ, Breur GJ, Widmer WR, Paulos CM, Xu LC, Grote LA, Low PS. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 2002, 46:1947-1955. 10.1002/art.10405, 12124880.
22. Wipke BT, Wang Z, Kim J, McCarthy TJ, Allen PM. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat Immunol 2002, 3:366-372. 10.1038/ni775, 11896393.
23. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006, 7:284-292. 10.1038/ni1306, 16444258.
24. Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Mottonen T, Nuutila P, Minn H. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 2003, 48:3077-3084. 10.1002/art.11282, 14613269.
25. Garrood T, Blades M, Haskard DO, Mather S, Pitzalis C. A novel model for the preclinical imaging of inflamed human synovial vasculature. Rheumatology (Oxford) 2009, 48:926-931. 10.1093/rheumatology/kep117, 19491304.
26. McQueen FM, Ostergaard M. Established rheumatoid arthritis - new imaging modalities. Best Pract Res Clin Rheumatol 2007, 21:841-856. 10.1016/j.berh.2007.05.001, 17870031.
27. D'Agostino MA, Conaghan P, Le Bars M, Baron G, Grassi W, Martin-Mola E, Wakefield R, Brasseur JL, So A, Backhaus M, Malaise M, Burmester G, Schmidely N, Ravaud P, Dougados M, Emery P. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis 2005, 64:1703-1709. 10.1136/ard.2005.037994, 1755310, 15878903.
28. Eckstein F, Burstein D, Link TM. Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed 2006, 19:822-854. 10.1002/nbm.1063, 17075958.
29. Williams TG, Holmes AP, Bowes M, Vincent G, Hutchinson CE, Waterton JC, Maciewicz RA, Taylor CJ. Measurement and visualisation of focal cartilage thickness change by MRI in a study of knee osteoarthritis using a novel image analysis tool. Br J Radiol 2010, 83:940-948. 10.1259/bjr/68875123, 20223905.
30. Bashir A, Gray ML, Burstein D. Gd-DTPA2- as a measure of cartilage degradation. Magn Reson Med 1996, 36:665-673. 10.1002/mrm.1910360504, 8916016.
31. Bashir A, Gray ML, Boutin RD, Burstein D. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 1997, 205:551-558.
32. Gray ML, Burstein D, Kim YJ, Maroudas A. 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications. J Orthop Res 2008, 26:281-291. 10.1002/jor.20482, 17876836.
33. Owman H, Tiderius CJ, Neuman P, Nyquist F, Dahlberg LE. Association between findings on delayed gadolinium-enhanced magnetic resonance imaging of cartilage and future knee osteoarthritis. Arthritis Rheum 2008, 58:1727-1730. 10.1002/art.23459, 18512778.
34. Williams A, Shetty SK, Burstein D, Day CS, McKenzie C. Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) of the first carpometacarpal (1CMC) joint: a feasibility study. Osteoarthritis Cartilage 2008, 16:530-532. 10.1016/j.joca.2007.11.002, 2384147, 18194872.
35. Miese FR, Ostendorf B, Wittsack HJ, Reichelt DC, Mamisch TC, Zilkens C, Lanzman RS, Schneider M, Scherer A. Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage - a feasibility study. Radiology 2010, 257:441-447. 10.1148/radiol.10100459, 20807848.
36. Lewis AR, Nolan MJ, Hodgson RJ, Benjamin M, Ralphs JR, Archer CW, Tyler JA, Hall LD. High resolution magnetic resonance imaging of the proximal interphalangeal joints. Correlation with histology and production of a three-dimensional data set. J Hand Surg Br 1996, 21:488-495. 10.1016/S0266-7681(96)80053-2, 8856541.
37. Erickson SJ, Kneeland JB, Middleton WD, Jesmanowicz A, Hyde J, Lawson TL, Foley WD. MR imaging of the finger: correlation with normal anatomic sections. AJR Am J Roentgenol 1989, 152:1013-1019.
38. Tan AL, Grainger AJ, Tanner SF, Shelley DM, Pease C, Emery P, McGonagle D. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthritis Rheum 2005, 52:2355-2365. 10.1002/art.21210, 16052535.
39. Tan AL, McGonagle D. Psoriatic arthritis: correlation between imaging and pathology. Joint Bone Spine 2010, 77:206-211. 10.1016/j.jbspin.2009.09.011, 20409741.
40. Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn Reson Med 2002, 47:751-758. 10.1002/mrm.10110, 11948737.
41. Taylor AM, Panting JR, Keegan J, Gatehouse PD, Amin D, Jhooti P, Yang GZ, McGill S, Burman ED, Francis JM, Firmin DN, Pennell DJ. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999, 9:220-227. 10.1002/(SICI)1522-2586(199902)9:2<220::AID-JMRI11>3.0.CO;2-A, 10077017.
42. Sharma R, Saini S, Ros PR, Hahn PF, Small WC, de Lange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK, Morris M, Lucas M. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data. J Magn Reson Imaging 1999, 9:291-294. 10.1002/(SICI)1522-2586(199902)9:2<291::AID-JMRI21>3.0.CO;2-#, 10077027.
43. Reynolds PR, Larkman DJ, Haskard DO, Hajnal JV, Kennea NL, George AJ, Edwards AD. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 2006, 241:469-476. 10.1148/radiol.2412050490, 17005768.
44. Stach CM, Bauerle M, Englbrecht M, Kronke G, Engelke K, Manger B, Schett G. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum 2010, 62:330-339.
45. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008, 452:580-589. 10.1038/nature06917, 2708079, 18385732.
46. Gompels LL, Lim NH, Vincent T, Paleolog EM. In vivo optical imaging in arthritis - an enlightening future?. Rheumatology (Oxford) 2010, 49:1436-1446. 10.1093/rheumatology/keq012, 20338885.
47. Kulka JP, Bocking D, Ropes MW, Bauer W. Early joint lesions of rheumatoid arthritis; report of eight cases, with knee biopsies of lesions of less than one year's duration. AMA Arch Pathol 1955, 59:129-150.
48. Schumacher HR, Kitridou RC. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum 1972, 15:465-485. 10.1002/art.1780150502, 4117789.
49. Hansch A, Frey O, Hilger I, Sauner D, Haas M, Schmidt D, Kurrat C, Gajda M, Malich A, Bräuer R, Kaiser WA. Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol 2004, 39:626-632. 10.1097/01.rli.0000139008.04288.fd, 15377942.
50. Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, Ebert B, Petzelt D, Macdonald R, Licha K, Schirner M, Krenn V, Kamradt T, Taupitz M. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 2006, 13:4-13. 10.1016/j.acra.2005.07.010, 16399028.
51. Andersson SE, Johansson A, Lexmuller K, Ekstrom GM. Physiological characterization of mBSA antigen induced arthritis in the rat. II. Joint blood flow, glucose metabolism, and cell proliferation. J Rheumatol 1998, 25:1778-1784.
52. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003, 2:214-221. 10.1038/nrd1033, 12612647.
53. Palframan R, Airey M, Moore A, Vugler A, Nesbitt A. Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis. J Immunol Methods 2009, 348:36-41. 10.1016/j.jim.2009.06.009, 19567252.
54. Patel AM, Moreland LW. Certolizumab pegol: a new biologic targeting rheumatoid arthritis. Expert Rev Clin Immunol 2010, 6:855-866. 10.1586/eci.10.69, 20979550.
55. Hansch A, Frey O, Sauner D, Hilger I, Haas M, Malich A, Brauer R, Kaiser WA. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 2004, 50:961-967. 10.1002/art.20112, 15022340.
56. Chen WT, Mahmood U, Weissleder R, Tung CH. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005, 7:R310-317. 10.1186/ar1483, 1065321, 15743478.
57. Simon GH, Daldrup-Link HE, Kau J, Metz S, Schlegel J, Piontek G, Saborowski O, Demos S, Duyster J, Pichler BJ. Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe. Eur J Nucl Med Mol Imaging 2006, 33:998-1006. 10.1007/s00259-006-0081-y, 16770602.
58. Gompels LL, Madden L, Lim NH, Inglis JJ, McConnell E, Vincent TL, Haskard DO, Paleolog EM. In vivo fluorescence imaging of E-selectin: Quantitative detection of endothelial activation in arthritis. Arthritis Rheum 2011, 63:107-117. 10.1002/art.30082, 20954188.
59. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 2004, 101:17867-17872. 10.1073/pnas.0408191101, 539314, 15601762.
60. Lang A, Horler D, Baici A. The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol 2000, 27:1970-1979.
61. Chang CH, Tang Y, Bronson R, Tung CH. Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes. Osteoarthritis Cartilage 2004, 12:239-244. 10.1016/j.joca.2003.11.005, 14972341.
62. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002, 99:377-382. 10.1073/pnas.012611099, 117568, 11752410.
63. Weissleder R, Tung CH, Mahmood U, Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999, 17:375-378. 10.1038/7933, 10207887.
64. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002, 105:2766-2771. 10.1161/01.CIR.0000017860.20619.23, 12057992.
65. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004, 50:2459-2465. 10.1002/art.20379, 15334458.
66. Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, Lane JH, Harriman G, Xu Y, Ocain T, Weissleder R, Mahmood U, Healy AM, Jaffee B. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum 2007, 56:117-128. 10.1002/art.22303, 17195214.
67. Wilson T, Hastings JW. Bioluminescence. Annu Rev Cell Dev Biol 1998, 14:197-230. 10.1146/annurev.cellbio.14.1.197, 9891783.
68. Iris B, Zilberman Y, Zeira E, Galun E, Honigman A, Turgeman G, Clemens T, Gazit Z, Gazit D. Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development. J Bone Miner Res 2003, 18:570-578. 10.1359/jbmr.2003.18.3.570, 12619943.
69. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 2002, 168:1441-1446.
70. Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001, 107:1293-1301. 10.1172/JCI12037, 209299, 11375419.
71. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 2009, 36(Suppl 1):S56-68. 10.1007/s00259-009-1078-0, 19194703.
72. Linke R, Kuwert T, Uder M, Forst R, Wuest W. Skeletal SPECT/CT of the peripheral extremities. AJR Am J Roentgenol 2010, 194:W329-335. 10.2214/AJR.09.3288, 20308478.
73. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 2000, 97:2767-2772. 10.1073/pnas.040570597, 16004, 10706610.
74. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA 2010, 107:4311-4316. 10.1073/pnas.0910283107, 2840175, 20160077.
75. Ostendorf B, Scherer A, Wirrwar A, Hoppin JW, Lackas C, Schramm NU, Cohnen M, Mödder U, van den Berg WB, Müller HW, Schneider M, Joosten LA. High-resolution multipinhole single-photon-emission computed tomography in experimental and human arthritis. Arthritis Rheum 2006, 54:1096-1104. 10.1002/art.21732, 16572444.
76. Ostendorf B, Mattes-Gyorgy K, Reichelt DC, Blondin D, Wirrwar A, Lanzman R, Muller HW, Schneider M, Modder U, Scherer A. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol 2010, 39:55-61. 10.1007/s00256-009-0761-3, 19669137.
77. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007, 188:586-592. 10.2214/AJR.06.1094, 17242272.
78. Buyukhatipoglu K, Clyne AM. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 2010,
79. Buyukhatipoglu K, Miller TA, Clyne AM. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: cellular uptake, toxicity and proliferation studies. J Nanosci Nanotechnol 2009, 9:6834-6843.
80. Aletaha D, Funovits J, Breedveld FC, Sharp J, Segurado O, Smolen JS. Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum 2009, 60:1242-1249. 10.1002/art.24433, 19404938.
81. Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005, 52:1020-1030. 10.1002/art.20982, 15818697.
82. Landewe R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125. 10.1002/art.22143, 17009230.
83. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boffers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004, 50:36-42. 10.1002/art.11481, 14730597.
84. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008, 58:2958-2967. 10.1002/art.23945, 18821687.
85. Lee L, Buckley C, Blades MC, Panayi G, George AJ, Pitzalis C. Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum 2002, 46:2109-2120. 10.1002/art.10464, 12209516.
86. Gold L, Polisky B, Uhlenbeck O, Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem 1995, 64:763-797. 10.1146/annurev.bi.64.070195.003555, 7574500.
87. Famulok M, Mayer G. Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol 1999, 243:123-136.
88. Watson SR, Chang YF, O'Connell D, Weigand L, Ringquist S, Parma DH. Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo. Antisense Nucleic Acid Drug Dev 2000, 10:63-75. 10.1089/oli.1.2000.10.63, 10805157.
89. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998, 273:20556-20567. 10.1074/jbc.273.32.20556, 9685413.
90. Csaky K. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls. Ophthalmology 2003, 110:879-881. 10.1016/S0161-6420(03)00095-2, 12750083.
91. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997, 4:809-816. 10.1016/S1074-5521(97)90114-9, 9384527.
92. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook G, Warren S, Schmidt PG. Tumor targeting by an aptamer. J Nucl Med 2006, 47:668-678.
93. Huang YF, Chang HT, Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 2008, 80:567-572. 10.1021/ac702322j, 18166023.
94. Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther 2006, 8:R77. 10.1186/ar1944, 1526647, 16646988.
95. Tsien RY. Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture). Angew Chem Int Ed Engl 2009, 48:5612-5626. 10.1002/anie.200901916, 19565590.
96. Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 2009, 324:804-807. 10.1126/science.1168683, 2763207, 19423828.
97. Razansky D, Distel M, Vinegoni C, Ma R, Perrimon N, Koster RW, Ntziachristos V. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo. Nat Photonics 2009, 3:412-417.